Global

科学

致力于研究对抗癌症、感染性疾病和自身免疫疾病的创新免疫疗法

首页 > 科学 > Dysfunction of NK Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression. Cell Metabolism 2018; 28:243-255
Dysfunction of NK Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression. Cell Metabolism 2018; 28:243-255
2018-07-19
分享至:

ICP备字:皖ICP备2022011087号-1 (皖)-非经营性-2022-0075 皖公网安备 34019102001077号 Copyright © 2022  合肥天港免疫药物有限公司 网站技术支持:网新科技